| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 523.68B | 516.13B | 506.87B | 527.26B | 501.87B | 434.74B |
| Gross Profit | 78.33B | 76.97B | 74.40B | 78.28B | 72.74B | 62.67B |
| EBITDA | 16.14B | 17.27B | 14.97B | 20.91B | 20.15B | 15.12B |
| Net Income | 9.03B | 7.84B | 6.49B | 12.53B | 12.02B | 7.57B |
Balance Sheet | ||||||
| Total Assets | 282.00B | 292.26B | 294.97B | 288.89B | 282.65B | 245.94B |
| Cash, Cash Equivalents and Short-Term Investments | 66.35B | 75.03B | 89.09B | 82.14B | 82.40B | 75.73B |
| Total Debt | 13.00B | 13.10B | 13.62B | 14.16B | 14.68B | 4.77B |
| Total Liabilities | 157.05B | 164.33B | 162.35B | 165.13B | 169.28B | 138.30B |
| Stockholders Equity | 123.61B | 126.59B | 131.51B | 122.93B | 112.74B | 107.16B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 3.69B | 9.05B | 4.56B | 2.98B | 8.75B |
| Operating Cash Flow | 0.00 | 8.93B | 11.45B | 7.91B | 7.16B | 13.35B |
| Investing Cash Flow | 0.00 | -11.88B | -1.46B | -3.70B | -3.14B | -5.46B |
| Financing Cash Flow | 0.00 | -10.52B | -4.54B | -4.92B | 1.24B | -3.29B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
81 Outperform | ¥86.48B | 136.93 | 5.02% | 3.23% | -10.00% | -51.92% | |
81 Outperform | ¥250.52B | 9.64 | 8.91% | 3.85% | 1.48% | 8.86% | |
78 Outperform | ¥113.71B | 12.40 | ― | 3.24% | 18.70% | 33.93% | |
76 Outperform | ¥88.39B | 19.06 | ― | 4.45% | 0.59% | -10.60% | |
74 Outperform | ¥60.12B | 24.26 | ― | 2.54% | 2.00% | 39.80% | |
70 Outperform | ¥125.45B | 12.83 | ― | 3.47% | 3.93% | 68.67% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% |